Navigation Links
Amsco 3085 SP™ Surgical Table

ProductsAmsco 3085 SP™ Surgical Table
Company STERIS Corporation
Item Amsco 3085 SP™ Surgical Table
Features 
  • Unprecedented versatility for every surgical specialty
  • Designed for flexibility in patient positioning
  • Exceptional image amplification (IA) coverage
  • Built-in safety and reliability
  • Twelve month parts and labor warranty.
Description The Amsco 3085 SP Surgical Table combines innovation and design to create exceptional positioning for patients weighing up to 1,000 lbs. You can safely raise and lower larger patients in both normal and reverse orientation and have virtually the same positioning capabilities as with other patients. The Amsco 3085 SP Table offers the same quality, reliability, and flexibility you-ve come to expect in all of our surgical equipment products.
Info STERIS Corporation
Customer Service: (800) JIT-4-USE
Web site: http://www.steris.com

Related medicine products :

1. Amsco OrthoVision Orthopedic and Fracture Table
2. HERMES-Ready Amsco 3085 SP Surgical Table
3. Amsco® 3080/3085 SP™ Bariatric Foot Extension
4. Amsco® 3080/3085 SP™ Bariatric Orthopedic Extension
5. Amsco® 3080/3085 SP™ Bariatric Table Extensions
6. Amsco® Power-Lift Stirrups
7. Amsco® Auto Lift Multi-Purpose Stirrups
8. Amsco® Power-Lift Bariatric Stirrups
9. No.12 Surgical Blade
10. No. SM68 Surgical Blade
11. Surgiscribe Surgical Marking Pens
Breaking Medicine Technology:Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 1Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 2Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 3Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 4Cardiologists Mobilize to Protect Quality Cardiac Care for Patients New Guarding Hearts Alliance 3A Heart Patients 26apos 3B Advocate in Congress 58226 5AMT Appoints New Chief Executive Officer 58224 1AMT Appoints New Chief Executive Officer 58224 2AMT Appoints New Chief Executive Officer 58224 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 1ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 2ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 3ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non Surgical Treatment of Eye Disease 5051 4